{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:41:04Z","timestamp":1792737664323,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/Y015347\/1"],"award-info":[{"award-number":["MR\/Y015347\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.xcrm.2025.102252","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T14:38:42Z","timestamp":1753713522000},"page":"102252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis"],"prefix":"10.1016","volume":"6","author":[{"given":"Mariana Pereira","family":"Pinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Antoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balraj","family":"Sandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Cerundolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megat H.B.A.","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maldonado-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Teague","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasullah Khalid","family":"Alham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Verrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon R.","family":"Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Rostron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally-Ann","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Waugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha","family":"Adwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3545-3758","authenticated-orcid":false,"given":"Tao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102252_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2025.102252_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/tbcr-24-15","article-title":"Expert consensus on the clinical application of immunotherapy in breast cancer: 2024","volume":"5","author":"Wang","year":"2024","journal-title":"Transl. Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2025.102252_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8+ T cells in cancer and cancer immunotherapy","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.20892\/j.issn.2095-3941.2021.0597","article-title":"Immunology and immunotherapy in breast cancer","volume":"19","author":"Semiglazov","year":"2022","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.xcrm.2025.102252_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2326-6066.CIR-13-0088","article-title":"Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers","volume":"2","author":"Yao","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2025.102252_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12885-019-5402-1","article-title":"The neoepitope landscape of breast cancer: Implications for immunotherapy","volume":"19","author":"Narang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaa4971","article-title":"Neoantigens in cancer immunotherapy","volume":"348","author":"Schumacher","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102252_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102252_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1607674","article-title":"Frequency determination of breast tumor-reactive CD4 and CD8 T cells in humans: unveiling the antitumor immune response","volume":"8","author":"Pinho","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102252_bib10","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.21.02170","article-title":"Breast Cancers Are Immunogenic: Immunologic Analyses and a Phase II Pilot Clinical Trial Using Mutation-Reactive Autologous Lymphocytes","volume":"40","author":"Zacharakis","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102252_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91358-1","article-title":"Neoantigens elicit T cell responses in breast cancer","volume":"11","author":"Morisaki","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102252_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41571-024-00935-6","article-title":"Precision therapeutics and emerging strategies for HR-positive metastatic breast cancer","author":"Lloyd","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102252_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674192","article-title":"The Immunology of Hormone Receptor Positive Breast Cancer","volume":"12","author":"Goldberg","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102252_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.983887","article-title":"Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients","volume":"12","author":"Muraro","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2025.102252_bib15","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1663107","article-title":"T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients","volume":"8","author":"Viborg","year":"2019","journal-title":"OncoImmunology"},{"key":"10.1016\/j.xcrm.2025.102252_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/ijc.11052","article-title":"Differences in T-cell immunity toward tumor-associated antigens in colorectal cancer and breast cancer patients","volume":"105","author":"Nagorsen","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib17","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.4049\/jimmunol.179.4.2627","article-title":"Functional T cell responses to tumor antigens in breast cancer patients have a distinct phenotype and cytokine signature","volume":"179","author":"Inokuma","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2025.102252_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Koboldt","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102252_bib72","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13073-015-0240-5","article-title":"TCLP: An online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression","volume":"7","author":"Scholtalbers","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.xcrm.2025.102252_bib19","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/jamaoncol.2016.1061","article-title":"Variation in the Incidence and Magnitude of Tumor-Infiltrating Lymphocytes in Breast Cancer Subtypes: A Systematic Review","volume":"2","author":"Stanton","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.xcrm.2025.102252_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12967-016-0983-9","article-title":"Differential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancer","volume":"14","author":"Miyan","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102252_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16020396","article-title":"The Emerging Role of Tertiary Lymphoid Structures in Breast Cancer: A Narrative Review","volume":"16","author":"Narvaez","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102252_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-35238-w","article-title":"A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer","volume":"14","author":"Tietscher","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102252_bib23","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102252_bib24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ccell.2022.03.005","article-title":"Transcriptomic profiles of neoantigen-reactive T cells in human gastrointestinal cancers","volume":"40","author":"Zheng","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102252_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.abl5447","article-title":"Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers","volume":"375","author":"Lowery","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102252_bib26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccell.2022.03.012","article-title":"A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancers","volume":"40","author":"Hanada","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102252_bib27","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1038\/s41467-018-05072-0","article-title":"Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors","volume":"9","author":"Duhen","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102252_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-018-0130-2","article-title":"Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates","volume":"557","author":"Simoni","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102252_bib29","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102252_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166740","article-title":"Breast cancer immunopeptidomes contain numerous shared tumor antigens","volume":"134","author":"Kina","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2025.102252_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.breast.2019.12.002","article-title":"Expression of tumor-associated antigens in breast cancer subtypes","volume":"49","author":"Curigliano","year":"2020","journal-title":"Breast"},{"key":"10.1016\/j.xcrm.2025.102252_bib32","doi-asserted-by":"crossref","first-page":"13493","DOI":"10.1073\/pnas.0906840106","article-title":"CT-X antigen expression in human breast cancer","volume":"106","author":"Grigoriadis","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2025.102252_bib33","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00726-011-0966-3","article-title":"Identification of a novel HLA-A2-restricted cytotoxic T lymphocyte epitope from cancer-testis antigen PLAC1 in breast cancer","volume":"42","author":"Liu","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.xcrm.2025.102252_bib34","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1038\/s41467-022-33720-z","article-title":"Evolution and modulation of antigen-specific T cell responses in melanoma patients","volume":"13","author":"Huuhtanen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102252_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153963","article-title":"Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor\u2013positive breast cancer","volume":"7","author":"Egelston","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.xcrm.2025.102252_bib36","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2025.102252_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.molonc.2010.04.004","article-title":"Histological types of breast cancer: How special are they?","volume":"4","author":"Weigelt","year":"2010","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.xcrm.2025.102252_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1758834016644156","article-title":"Differences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implications","volume":"8","author":"Barroso-Sousa","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.xcrm.2025.102252_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-25357-0","article-title":"Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism","volume":"8","author":"Du","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102252_bib40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/jnci\/djx268","article-title":"Immune Infiltration in Invasive Lobular Breast Cancer","volume":"110","author":"Desmedt","year":"2018","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.xcrm.2025.102252_bib41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s43018-023-00527-w","article-title":"Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment","volume":"4","author":"Onkar","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106517","article-title":"Estrogen receptor regulation of the immune microenvironment in breast cancer","volume":"240","author":"McGuinness","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.102252_bib43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4048\/jbc.2021.24.e4","article-title":"Relation Between Tumor Size and Lymph Node Metastasis According to Subtypes of Breast Cancer","volume":"24","author":"Min","year":"2021","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib44","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102252_bib45","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/j.immuni.2021.08.019","article-title":"Resident memory CD8+ T cells in regional lymph nodes mediate immunity to metastatic melanoma","volume":"54","author":"Molodtsov","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.102252_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17046-2","article-title":"Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients","volume":"11","author":"N\u00fa\u00f1ez","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102252_bib47","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ejca.2009.03.024","article-title":"Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer","volume":"45","author":"Nakamura","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102252_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154735","article-title":"Breast cancer vaccines; A comprehensive and updated review","volume":"249","author":"Al-Hawary","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.xcrm.2025.102252_bib50","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41573-023-00809-z","article-title":"T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome","volume":"22","author":"Klebanoff","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.102252_bib51","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/cancers16010124","article-title":"Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential","volume":"16","author":"Chamorro","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.xcrm.2025.102252_bib52","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/2159-8290.CD-24-0168","article-title":"TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer","volume":"14","author":"Kortleve","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.102252_bib53","first-page":"5924","article-title":"PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer","volume":"15","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.xcrm.2025.102252_bib54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s12967-023-04292-3","article-title":"Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments","volume":"21","author":"Dagar","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.102252_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102868","article-title":"CAR-T cell therapy for breast cancer: Current status and future perspective","volume":"133","author":"Buono","year":"2025","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.xcrm.2025.102252_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1385571","article-title":"CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies","volume":"15","author":"Niu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.102252_bib57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2017.11.043","article-title":"Antigen Identification for Orphan T Cell Receptors Expressed on Tumor-Infiltrating Lymphocytes","volume":"172","author":"Gee","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102252_bib58","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1016\/j.cell.2023.06.020","article-title":"Targeting of multiple tumor-associated antigens by individual T cell receptors during successful cancer immunotherapy","volume":"186","author":"Dolton","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102252_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/14712598.2024.2370395","article-title":"Checkpoint inhibition for early-stage hormone receptor-positive breast cancer","volume":"24","author":"Schlam","year":"2024","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.xcrm.2025.102252_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103695","article-title":"Immunotherapy in the treatment landscape of hormone receptor-positive (HR+) early breast cancer: is new data clinical practice changing?","volume":"9","author":"Zagami","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.xcrm.2025.102252_bib71","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gkx760","article-title":"VDJdb: a curated database of T-cell receptor sequences with known antigen specificity","volume":"46","author":"Shugay","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102252_bib66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102252_bib67","article-title":"immunarch: An R Package for Painless Bioinformatics Analysis of T-Cell and B-Cell Immune Repertoires","year":"2019","journal-title":"Zenodo"},{"key":"10.1016\/j.xcrm.2025.102252_bib68","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","article-title":"circlize implements and enhances circular visualization in R","volume":"30","author":"Gu","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102252_bib69","unstructured":"Hetzel, J.-P., Saeedghalati, M. cre, Farahpour, F., and Hoffmann, D. (2023). turboGliph: Find Specificity Groups with GLIPH and GLIPH2 Method. https:\/\/github.com\/HetzDra\/turboGliph\/blob\/main\/DESCRIPTION."},{"key":"10.1016\/j.xcrm.2025.102252_bib70","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1093\/bioinformatics\/btx469","article-title":"ggseqlogo: a versatile R package for drawing sequence logos","volume":"33","author":"Wagih","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.102252_bib75","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"key":"10.1016\/j.xcrm.2025.102252_bib76","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.102252_bib77","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41592-018-0033-z","article-title":"SAVER: gene expression recovery for single-cell RNA sequencing","volume":"15","author":"Huang","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2025.102252_bib61","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jcyt.2016.01.005","article-title":"Dendritic-tumor cell hybrids induce tumor-specific immune responses more effectively than the simple mixture of dendritic and tumor cells","volume":"18","author":"Pinho","year":"2016","journal-title":"Cytotherapy"},{"key":"10.1016\/j.xcrm.2025.102252_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105396","article-title":"Near-Complete Remission of Glioblastoma in a Patient Treated with an Allogenic Dendritic Cell-Based Vaccine: The Role of Tumor-Specific CD4+T-Cell Cytokine Secretion Pattern in Predicting Response and Recurrence","volume":"23","author":"Pinho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.102252_bib63","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41590-024-01802-3","article-title":"Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity","volume":"25","author":"Hamid","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102252_bib64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41590-021-01084-z","article-title":"An immunodominant NP105\u2013113-B\u221707:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease","volume":"23","author":"Peng","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2025.102252_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102252_bib73","doi-asserted-by":"crossref","first-page":"D816","DOI":"10.1093\/nar\/gkn673","article-title":"CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens","volume":"37","author":"Almeida","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102252_bib74","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1634\/theoncologist.2014-0372","article-title":"Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression","volume":"20","author":"Cheang","year":"2015","journal-title":"Oncologist"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125003258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125003258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:22:33Z","timestamp":1772918553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125003258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":77,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666379125003258"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102252","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-specific CD8 T cell characterization in HR+ breast cancer reveals an impaired antitumoral response in patients with lymph node metastasis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102252"}}